Moreover, these optimized NGS can detect low-frequency variants, known as variants of unknown significance (VUS), but the clinical relevance of these variants, which may reflect CHIP non-tumor cfDNA, remains unclear [56,57]. Here, STUB1 is linked to neoplasm.